ACTA PHARMACEUTICA
SCI一区
EI同步收录
月刊
高认可度
更新时间: 浏览量:
期刊基础介绍
Acta Pharmaceutica (AP) is an international, scientific, multidisciplinary journal, devoted to the pharmaceutical and allied sciences, which contains articles predominantly on core biomedical and health subjects. The aim of AP is to increase the impact of pharmaceutical research in academia, industry and laboratories. With a strong emphasis on quality and originality, AP publishes reports from the discovery of a drug up to clinical practice, in the form of preliminary and short communications, original research papers and reviews. Book reviews are published also.
AP is a quarterly, single-blind peer-reviewed journal in biomedicine with fully open access and “early bird” platform. All articles are submitted to scrutinized evaluation and fair judgement. AP above all puts scientific honesty and integrity.
To reach the highest standards in publication ethics all the parties (authors, editors, reviewers) are required to behave responsibly and ethically. This implies submittance by authors on an exclusive basis, of only their own and new data; novelty and originality are prioritized. Also, secure handling of confidential data by reviewers and editors is a must.
AP is indexed in numerous world top international bibliographic bases, like Clarivate Analytics´s Web of Science® Core Collection (SCI-Expanded, JCR/Science Edition, etc.), EMBASE/Excerpta Medica, MEDLINE/PubMed, Scopus/SCImago, and others. According to SCImago JR it is a Q2 journal (pharmaceutical sciences) with a steadily increasing Clarivate JIF value reaching 2.8 in 2022.
Topics covered are:
• drug design
• molecular modelling/docking studies
• pharmaceutical chemistry/medicinal chemistry
• drug metabolism
• analytics of drugs
• pharmaceutical technology/formulation studies/nanosystems/cosmetology
• pharmaceutical biotechnology
• pharmaceutics/biopharmacy (including pharmacokinetics) and pharmacodynamics
• drug delivery/disposition and stability
• pharmacognosy and phytopharmacy
• pharmacology (clinical and animal)
• toxicology
• clinical pharmacy
• pharmacovigilance
• pharmaceutical and clinical biochemistry
• pharmaceutical biology with genetics/pharmacogenomics/cell biology
• pharmacoepidemiology/pharmacoeconomics/social pharmacy
• physical pharmacy
• radiopharmaceuticals
• medicine (including diagnostics and therapy)
• peptide and protein chemistry/protein design
AP is a quarterly, single-blind peer-reviewed journal in biomedicine with fully open access and “early bird” platform. All articles are submitted to scrutinized evaluation and fair judgement. AP above all puts scientific honesty and integrity.
To reach the highest standards in publication ethics all the parties (authors, editors, reviewers) are required to behave responsibly and ethically. This implies submittance by authors on an exclusive basis, of only their own and new data; novelty and originality are prioritized. Also, secure handling of confidential data by reviewers and editors is a must.
AP is indexed in numerous world top international bibliographic bases, like Clarivate Analytics´s Web of Science® Core Collection (SCI-Expanded, JCR/Science Edition, etc.), EMBASE/Excerpta Medica, MEDLINE/PubMed, Scopus/SCImago, and others. According to SCImago JR it is a Q2 journal (pharmaceutical sciences) with a steadily increasing Clarivate JIF value reaching 2.8 in 2022.
Topics covered are:
• drug design
• molecular modelling/docking studies
• pharmaceutical chemistry/medicinal chemistry
• drug metabolism
• analytics of drugs
• pharmaceutical technology/formulation studies/nanosystems/cosmetology
• pharmaceutical biotechnology
• pharmaceutics/biopharmacy (including pharmacokinetics) and pharmacodynamics
• drug delivery/disposition and stability
• pharmacognosy and phytopharmacy
• pharmacology (clinical and animal)
• toxicology
• clinical pharmacy
• pharmacovigilance
• pharmaceutical and clinical biochemistry
• pharmaceutical biology with genetics/pharmacogenomics/cell biology
• pharmacoepidemiology/pharmacoeconomics/social pharmacy
• physical pharmacy
• radiopharmaceuticals
• medicine (including diagnostics and therapy)
• peptide and protein chemistry/protein design
期刊核心参数
通讯方式
HRVATSKO FARMACEUTSKO DRUSTOV (HFD)-CROATION PHARMACEUTICAL SOC, MASARYKOVA 2, ZAGREB, CROATIA, 10000
涉及的研究方向
PHARMACOLOGY & PHARMACY-
出版国家或地区
CROATIA
出版语言
English
年文章数
43
PubMed Central (PMC)链接
CITESCORE
| CiteScore | SJR | SNIP | CiteScore排名 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.50 | 0.398 | 0.607 |
|
WOS期刊JCR分区
WOS分区等级:4区| 按JIF指标学科分区 | 收录子集 | JIF分区 | JIF排名 | JIF百分位 |
| 学科:PHARMACOLOGY & PHARMACY | SCIE | Q4 | 280/352 |
|
| 按JCI指标学科分区 | 收录子集 | JCI分区 | JCI排名 | JCI百分位 |
| 学科:PHARMACOLOGY & PHARMACY | SCIE | Q3 | 216/353 |
|
期刊分区表预警名单
2025年03月发布的2025版:不在预警名单中2024年02月发布的2024版:不在预警名单中
2023年01月发布的2023版:不在预警名单中
2021年12月发布的2021版:不在预警名单中
2020年12月发布的2020版:不在预警名单中
中科院2025年3月升级版
点击查看中国科学院期刊分区趋势图| 大类学科 | 小类学科 | Top期刊 | 综述期刊 | ||
|---|---|---|---|---|---|
| 医学 4区 |
| 否 | 否 |
中科院2023年12月旧的升级版
| 大类学科 | 小类学科 | Top期刊 | 综述期刊 | ||
|---|---|---|---|---|---|
| 医学 4区 |
| 否 | 否 |